Over the years, there has been a growing focus on the development of safe and effective novel antiviral therapeutics owing to the rising cases of life-threatening viral diseases

Roots Analysis is pleased to announce the publication of its recent study, titled, “Antiviral Drugs Market, 2022 – 2035”

To get a sample copy of the latest market report, visit

https://www.rootsanalysis.com/reports/antiviral-drugs-market/request-sample.html

The study features an in-depth analysis, highlighting the capabilities of antiviral drug developers engaged in this domain. Amongst other elements, the report features:

• A detailed assessment of the current market landscape of commercially available antiviral drugs. 
• A detailed assessment of the current market landscape of clinical-stage antiviral drugs.
• An analysis of the partnerships that have been inked by stakeholders engaged in this domain, during the period 2019-2022 (till May).
• A detailed analysis of investments that have been made into companies engaged in the antiviral drugs domain, during the period 2019-2022 (till May).
• A qualitative analysis of the five competitive forces under an insightful Porter’s Five Forces framework.
• Elaborate profiles of prominent players (shortlisted based on a proprietary criterion) engaged in development of antiviral drugs.
• A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below):
  • Mechanism of Action
• Fusion Inhibitors
• DNA Polymerases
• Protease Inhibitors
• Reverse Transcriptase Inhibitors
• Other Mechanisms

• Target Indication

• Human Immunodeficiency Virus Infection
• Hepatitis
• Herpes Simplex Virus Infection
• Cytomegalovirus Infection\
• Influenza
• Coronavirus Infection
• Other Target Indications

• Type of Drug Target

• Virus Targets
• Host Targets

• Type of Therapy

• Monotherapy
• Combination Therapy

• Key Geographical Regions 

• North America
• Europe
• Asia-Pacific
• Latin America
• MENA
• Rest of the World 

Key companies covered in the report

• AbbVie
• AstraZeneca
• Bristol-Myers Squibb
• Genentech
• Gilead Sciences
• GlaxoSmithKline (GSK)
• Johnson & Johnson
• Merck
• Novartis
• Pfizer
• Roche
• ViiV Healthcare

For additional details, please visit https://www.rootsanalysis.com/reports/antiviral-drugs-market.html

You may also be interested in the following titles:

DNA Encoded Libraries

Quantum Computing in Drug Discovery Services Market

You may also like to learn what our experts are sharing in Roots educational series:

mRNA Therapeutics and mRNA Vaccines Industry: Current Scenario and Future Trends

Novel Cell Cytometers: Need of the Hour

About Roots Analysis

Roots Analysis is a global leader in the pharma / biotech market research. Having worked with over 750 clients worldwide, including Fortune 500 companies, start-ups, academia, venture capitalists and strategic investors for more than a decade, we offer a highly analytical / data-driven perspective to a network of over 450,000 senior industry stakeholders looking for credible market insights.

Contact:

Ben Johnson

+1 (415) 800 3415

Ben.johnson@rootsanalysis.com